What is the price of DelMar Pharmaceuticals, Inc. (DMPWW)

The price of DelMar Pharmaceuticals, Inc. (DMPWW) is $0.005

What is the market cap of DelMar Pharmaceuticals, Inc. (DMPWW)

The market cap of DelMar Pharmaceuticals, Inc. (DMPWW) is $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Price and Market Cap

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Price of DMPWW	Asset B	Mkt. of B	Results
$15,477,429 $1.74K	NVDA	$5.383T	+309,548,585,950.26%
$12,717,472 $1.74K	AAPL	$4.423T	+254,349,445,230.23%
$11,956,561 $1.74K	GOOG	$4.159T	+239,131,220,200.79%
$10,532,232 $1.74K	MSFT	$3.663T	+210,644,634,308.60%
$8,312,428 $1.74K	AMZN	$2.891T	+166,248,564,985.39%

Price of DMPWW

Asset B

Mkt. of B

Results

$15,477,429 $1.74K